Pfizer reports strong first-quarter 2021 results
Following the completion of the spin-off of the Upjohn Business (4) in the fourth quarter of 2020, Pfizer now operates as a focused innovative biopharmaceutical company engaged in the discovery, development, manufacturing, marketing, sales and distribution of biopharmaceutical products worldwide. Revenues and expenses associated with the Upjohn Business (4) for first-quarter 2020 have been recategorized as discontinued operations and excluded from Adjusted (2) results. Pfizer’s Meridian subsidiary, the manufacturer of EpiPen and other auto-injector products, which had been reported within t...
Source: miragenews.com